The effects of re-expressing Tip60 in breast cancer cells with varying levels of endogenous Tip60 expression would allow evaluation if the down-regulation/mislocalisation of Tip60 is part of an anti-apoptotic mechanism for tumour progression in breast cancer and if it is a cause or consequence of progression. The gene discussed is KAT5; the disease is breast carcinoma.